NSE ScannerComparison · NSE · data 2026-10-31
Hester Biosciences Limited vs Sakar Healthcare Ltd
In plain words
Size: Sakar Healthcare Ltd is about 1.1 times the market value of Hester Biosciences Limited.
Valuation (P/E): Sakar Healthcare Ltd 49 vs Hester Biosciences Limited 14.3.
Return on equity: Hester Biosciences Limited 16.5% vs Sakar Healthcare Ltd 10%.
Profit growth over 3 years: Sakar Healthcare Ltd 33.7% a year vs Hester Biosciences Limited 27.8% a year.
Debt to equity: Hester Biosciences Limited 0.54 vs Sakar Healthcare Ltd 0.17.
Differences in the numbers, not a recommendation of either stock.
Side by side
| HESTERBIO | SAKAR | |
|---|---|---|
| Price | ₹2,289.3 | ₹944.8 |
| Market cap | ₹1,956 cr | ₹2,074 cr |
| P/E | 14.3 | 49 |
| P/B | — | 6.1 |
| ROE | 16.5% | 10.0% |
| ROCE | 13.0% | 12.4% |
| Debt / equity | 0.54 | 0.17 |
| Operating margin | 19.9% | 21.5% |
| Dividend yield | 0.48% | 0.00% |
| Sales growth, 3 years (yearly) | 7.7% | 23.6% |
| Profit growth, 3 years (yearly) | 27.8% | 33.7% |
| 1-year return | 40.7% | 167.0% |
| Revenue, last 12 months | ₹326 cr | ₹302 cr |
| Net profit, last 12 months | ₹136 cr | ₹43 cr |
| Latest quarter | Sept 2025 | — |
| Quarter net profit | ₹14 cr | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 53.73% | 51.70% |
| Health check | Strong (8.4/10) | Strong (7.1/10) |
Common questions
Which has a higher P/E, Hester Biosciences Limited or Sakar Healthcare Ltd?
Sakar Healthcare Ltd trades at the higher P/E (49 against 14.3). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Hester Biosciences Limited (16.5% against 10.0%).
Which carries more debt?
Hester Biosciences Limited has the higher debt-to-equity ratio (0.54 against 0.17).